Delivery Order SPE2DB20D3101-SPE2DB22FG9W2
Award Date 10/15/21
Potential Completion Date 10/18/21
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 40 mg tablets, a cardiovascular medication, with a ceiling value of $3,304.55 and a performance period through April 2024. The contract is a delivery order, with a firm fixed price, and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.22, is for the delivery of 4560784583 units of Atorvastatin 40 mg tablets to support military healthcare programs. The award is a Delivery Order contract with a firm-fixed price pricing type, with a completion date of May 2, 2023. This contract is not designated as a set-aside and was...
- This federal contract award, valued at $1,668.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,600 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of March 18, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,228.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,906,764 units of Atorvastatin 40 mg tablets, a common cardiovascular medication. The award does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $3,155.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 40 mg tablets in quantities of 1,000 to support military healthcare programs. This is a delivery order contract with a firm fixed price arrangement. The contract has an ultimate completion date of July 9, 2024 and was awarded on July 8, 2024....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,094.07 firm fixed-price delivery order is for the supply of 4,561,290 units of Atorvastatin 10 mg tablets, a cardiovascular medication, with a completion date of June 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $1,589.39 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,564,075 units of Atorvastatin 40 mg tablets, a generic pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price pricing type and an ultimate completion date of March 27, 2024....
- This federal contract award, valued at $3,223.60, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 4,562,417,388 units of Atorvastatin 40 mg tablets, with a period of performance through October 10, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,593.61 firm fixed-price delivery order is for the supply of 4,563,144 units of the cardiovascular medication Atorvastatin 40 mg tablets. The contract has an ultimate completion date of December 20, 2023 and was awarded on December 19, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.38, is for the delivery of Atorvastatin 40 mg tablets (1,000 per bottle) and has a completion date of June 14, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...